<DOC>
	<DOCNO>NCT00419068</DOCNO>
	<brief_summary>The purpose study determine whether vitamin D enhance response standard antibiotic treatment pulmonary tuberculosis .</brief_summary>
	<brief_title>Trial Adjunctive Vitamin D Tuberculosis Treatment</brief_title>
	<detailed_description />
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Tuberculosis , Pulmonary</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Suspected smear positive pulmonary tuberculosis . Age 18 year old . Written inform consent participate . Known intolerance vitamin D firstline antituberculous therapy . Taking antituberculous therapy six day six month precede enrolment . Taking following medication month precede enrolment : oral corticosteroid therapy , immunosuppressant therapy cytotoxic therapy . Taking follow medication enrolment : benzothiadiazine derivative , cardiac glycoside antituberculous therapy rifampicin , isoniazid , pyrazinamide ethambutol . Diagnosis follow : sarcoidosis , hyperparathyroidism , nephrolithiasis , pulmonary silicosis , HIV infection , liver failure , renal failure malignancy Infection rifampicinresistant organism ( demonstrate rapid molecular test ) Biochemical disturbance enrolment : serum correct calcium &gt; 2.66 mmol/l , serum AST &gt; 120 IU/l , total serum bilirubin &gt; 40 micromol/l serum creatinine &gt; 250 micromol/l Breastfeeding pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>